Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Synthesis and Evaluation of New Magneto-Fluorescent Carbon Dot Based on Manganese Citrate for Mri Imaging Publisher Pubmed



Ali V1 ; Kefayati H1 ; Shafiee Ardestani M2 ; Pourahmad A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Chemistry, Islamic Azad University, Rasht Branch, Rasht, Iran
  2. 2. Faculty of Pharmacy, Department of Radiopharmacy, Tehran University of Medical Sciences, Tehran, Iran

Source: Magnetic Resonance Materials in Physics# Biology and Medicine Published:2024


Abstract

Objective: Medical imaging techniques have widely revolutionized the diagnosis and treatment of various health conditions. Among these techniques, magnetic resonance imaging (MRI) has stood out as a noninvasive and versatile tool. Now, a breakthrough innovation called “manganese-carbon dots” is poised to enhance MRI imaging and provide physicians with even greater insight into the human body. Materials and methods: In this study, one-pot hydrothermal method was used to fabricate magneto-fluorescent carbon quantum dots using manganese citrate, urea, and Mn2+. Manganese citrateAQ3 acted as a carbon source and contrast agent. TEM,XPS, FTIR, UV–Vis, fluorescent analysis confirmed the successful synthesis of magneto-fluorescent carbon quantum dots. The MTT assay was used to study its biocompatiblity, Finallay application of itscompound for mri imaging was investigated. Results: Characterization Techniques confirmed the succesful synthesis of product. MTT assay showed no toxicity of this product on HEK-293 cells. In addition, it exhibited high r1 relaxivity (7.4 mM–1 S−1) suggesting excellent potential of magneto-fluorescent carbon quantum dots as MRI T1 contrast agent and enabling specific imaging. Conclusion: Based on the results obtained, the synthesized carbon quantum dots could be used as fluorescence/MRI bimodal platform for in vivo imaging. © The Author(s), under exclusive licence to European Society for Magnetic Resonance in Medicine and Biology (ESMRMB) 2023.